跳至主要内容
临床试验/JPRN-jRCTs031220373
JPRN-jRCTs031220373进行中(未招募)3 期

Randomized, double-blind, placebo-controlled parallel-group comparative study to evaluate the effect of high-dose nicotinamide mononucleotide (NMN) on aging

Yamauchi Toshimasa0 个研究点目标入组 62 人开始时间: 2022年10月11日最近更新:
适应症

试验速览

阶段
3 期
状态
进行中(未招募)
发起方
入组人数
62

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 65age old 至 ot applicable(—)
性别
All

入选标准

  • 1. Non-smoker
  • 2. Aged 65 years old or older at the time of informed consent is taken
  • 3. Male or female
  • 4. Able to attend all scheduled visits
  • 5. Able and willing to give written informed consent

排除标准

  • 1. Taking health food
  • 2. With severe hearing loss or wearing a hearing aid in daily life
  • 3. Taking more than 1 hour daily exercise for more than 6 months
  • 4. With a pacemaker
  • 5. Taking medicine, including Chinese medicine
  • 6. Having history of treatment for cancer, heart failure and myocardial infarction
  • 7. With atrial fibrillation, arrhythmia, liver failure, renal failure, cerebrovascular disease, rheumatoid arthritis and other chronic diseases except diabetes, dyslipidemia and hypertension
  • 8. Suspected of having viral hepatitis, HIV or syphilis
  • 9. With drug allergy or with food allergy to health food related to this study
  • 10. Participated in other clinical trials within 3 months
  • 11. Judged as ineligible by clinical investigators

研究者

发起方
Yamauchi Toshimasa

相似试验